Apellis Pharmaceuticals (NASDAQ:APLS) is gearing up to announce its quarterly earnings on Tuesday, 2024-11-05. Here’s a quick overview of what investors should know before the release. Analysts are estimating that Apellis Pharmaceuticals will report an earnings per share (EPS) of $-0.29. Apellis Pharmaceuticals bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter. New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but …